At 12 weeks, the pa tient com plained of tremor, nau sea, micrographia, and shuffling gait. These symp toms had emerged within 10 weeks of the ini tial bupropion pre scrip tion. He dis con tin ued the bupropion and the symp toms re solved over 10 days. The de pres sion wors ened, how ever, as the extrapyramidal symptoms re solved. At tempts at re in tro ducing the bupropion at lower doses were un suc cess ful, and the pa tient now contin ues on nefazodone plus fluoxetine, with the ad di tion of light treat ment, with sig nif i cant clin i cal im prove ment.
A re view of the lit er a ture from the Drug In for ma tion Ser vice showed 2 case reports of re vers ible orofacial dyskinesia af fect ing the eyes and tongue in a 70-year-old woman re ceiv ing bupropion at doses from 75 to 225 mg daily. Other symp toms in cluded hand tremor, nau sea, and diz zi ness. Af ter discon tinu a tion, the dyskinesia re ceded, and other side ef fects dis ap peared.
Two other ge ri at ric pa tients (aged 85 and 72 years) were treated with bupropion for ma jor de pres sion and expe ri enced a "fall ing back ward" re ac tion. Max i mum dos ages in each pa tient were up to 400 mg and 350 mg daily, re spectively. Nei ther pa tient had a his tory of orthostatic hypotension or ver tigo. Both did man i fest other symp toms con sis tent with parkinsonian syn drome (for ex ample, akinesia and shuf fling gait). Af ter bupropion was dis con tin ued, these adverse ef fects re solved within 1 to 2 weeks.
The lit er a ture sug gests that at ther a peutic doses bupropion ex hib its do pamine-ag o nist ef fects, and at high doses it may have a do pa mine-an tag o nist ef fect. The man u fac turer does have some case re ports pre-and postmarketing of parkinsonian-type side ef fects, but no causal re la tion has yet been es tab lished.
There was 1 re port of a 53-year-old patient who had a dystonic re ac tion with nefazadone 2 hours af ter the first dose. This pa tient's chief com plaint was lip smack ing, with hand and arm ges tur ing. The symp toms re solved within 1 hour in re sponse to diphenhydramine and benztropine. The Drug In for ma tion search did not yield any ki netic in ter actions be tween nefazadone and bupropion that might have re sulted in a fur ther in crease in bupropion se rum levels. There was no fam ily his tory of neuro log i cal dis or der or Par kin son's dis ease in this pa tient. 
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Dear Ed i tor:
It is en cour ag ing to see fur ther study of com mu nity psy chi at ric prac tice (1) . Dr Freeland and oth ers state, "it would seem un likely that com mu nity psy chi atry elec tives would be pop u lar at the PGY5 stage of train ing," but I would like to pro vide a dif fer ent ex pe ri ence.
For the last 3 years, the multispeciality com mu nity train ing net work at the Univer sity of West ern On tario has, un der the di rec tor ship of Dr James Rourke, offered elec tive com mu nity psy chi at ric ex pe ri ence in ru ral prac tice. The elec tive is of fered in all years of train ing. To date, 3 res i dents, all at the PGY5 level, have used this op por tu nity to com plete a 3-to 6-month ro ta tion. In fol low-up, all res idents in di cated that this train ing ex pe rience was most ap pro pri ate for PGY4 and PGY5 res i dents. One res i dent has sub se quently gone on to prac tise in ru ral com mu nity psy chi a try, de spite no prior ca reer pref er ence. All res i dents in dicated a pos i tive ex pe ri ence with the elec tive.
These data, al though ob vi ously lim ited, sup port of fer ing com mu nity psy chi at ric elec tives to all stages of train ing in an effort to en cour age a ca reer choice in this needed area.
